Dephosphorylated uncarboxylated Matrix-Gla-Protein as candidate biomarker for immune-mediated vascular remodeling and prognosis in pulmonary hypertension
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Dephosphorylated uncarboxylated Matrix-Gla-Protein as candidate biomarker for immune-mediated vascular remodeling and prognosis in pulmonary hypertension ; volume:14 ; number:1 ; day:4 ; month:11 ; year:2024 ; pages:1-12 ; date:12.2024
Scientific reports ; 14, Heft 1 (4.11.2024), 1-12, 12.2024
- Creator
-
Tobal, R.
Potjewijd, J.
Vries, F. de
Doorn, D. P.C. van
Jaminon, A.
Bittner, R.
Akbulut, C.
Empel, V. van
Heeringa, P.
Damoiseaux, J.
Schurgers, L.
Paassen, P. van
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-77000-w
- URN
-
urn:nbn:de:101:1-2501222111384.462304008751
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 5:40 AM UTC
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tobal, R.
- Potjewijd, J.
- Vries, F. de
- Doorn, D. P.C. van
- Jaminon, A.
- Bittner, R.
- Akbulut, C.
- Empel, V. van
- Heeringa, P.
- Damoiseaux, J.
- Schurgers, L.
- Paassen, P. van
- SpringerLink (Online service)
Other Objects (12)
Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients
TLE3 as a candidate biomarker of response to taxane therapy
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy
Immune-mediated neurological complications and dengue
TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas
Mannosylated lipoarabinomannan in serum as a biomarker candidate for subclinical bovine tuberculosis
Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
The discovery and identification of a candidate proteomic biomarker of active tuberculosis
LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
Immune-Mediated Coagulopathy in COVID-19 Infection
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients
TLE3 as a candidate biomarker of response to taxane therapy
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy
Immune-mediated neurological complications and dengue
TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas
Mannosylated lipoarabinomannan in serum as a biomarker candidate for subclinical bovine tuberculosis
Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
The discovery and identification of a candidate proteomic biomarker of active tuberculosis
LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
Immune-Mediated Coagulopathy in COVID-19 Infection
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients
TLE3 as a candidate biomarker of response to taxane therapy
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy
Immune-mediated neurological complications and dengue
TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas
Mannosylated lipoarabinomannan in serum as a biomarker candidate for subclinical bovine tuberculosis
Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
The discovery and identification of a candidate proteomic biomarker of active tuberculosis
LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
Immune-Mediated Coagulopathy in COVID-19 Infection
Management of Immune-Mediated Paraneoplastic Neurological Disorders